A phase I dose escalation and expansion trial of the next-generation oral SERD camizestrant in women with ER-positive, HER2-negative advanced breast cancer: SERENA-1 monotherapy results
Titel:
A phase I dose escalation and expansion trial of the next-generation oral SERD camizestrant in women with ER-positive, HER2-negative advanced breast cancer: SERENA-1 monotherapy results
Auteur:
Hamilton, E. Oliveira, M. Turner, N. GarcĂa-Corbacho, J. Hernando, C. Ciruelos, E.M. Kabos, P. Ruiz-Borrego, M. Armstrong, A. Patel, M.R. Vaklavas, C. Twelves, C. Boni, V. Incorvati, J. Brier, T. Gibbons, L. Klinowska, T. Lindemann, J.P.O. Morrow, C.J. Sykes, A. Baird, R.D.